GlassScriptPhysician profile
Ann D Kim
NPI 1588829352
$4,110.35
in general payments reported to CMS, 2019-2025
35 companies · $618 in 2025
The $618 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $314 · 2021: $512 · 2022: $627 · 2023: $480 · 2024: $587 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $384.31 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $380.47 | 2019-2024 | Trulance, Xifaxan |
| Amgen INC. | $377.67 | 2021-2025 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.50 | 2019-2023 | Jardiance, Synjardy |
| Exact Sciences Corporation | $251.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $217.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $190.34 | 2019-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $186.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $177.87 | 2020-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $163.55 | 2022-2025 | Freestyle Libre |
| Allergan, INC. | $153.30 | 2019-2020 | |
| Radius Health, INC. | $122.04 | 2019 | |
| Intuity Medical INC | $113.57 | 2022 | |
| Gilead Sciences, INC. | $113.50 | 2021-2025 | |
| Vertiflex, INC. | $99.99 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $98.32 | 2023 | Krystexxa |
| Sanofi-Aventis U.S. LLC | $88.38 | 2019 | |
| Arbor Pharmaceuticals, INC. | $84.76 | 2019-2021 | |
| Dynavax Technologies Corporation | $67.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $54.78 | 2019-2023 | Steglatro, Belsomra |
| Amarin Pharma, INC. | $51.77 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.51 | 2022 | |
| Dexcom, INC. | $48.61 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $44.79 | 2022-2025 | Shingrix |
| Vivus LLC | $41.24 | 2020 | |
| Indivior INC. | $30.00 | 2023-2025 | Sublocade |
| Genentech USA, INC. | $25.70 | 2019-2020 | |
| Corcept Therapeutics | $23.20 | 2025 | Korlym |
| Medicomp INC | $21.45 | 2025 | Telepatch Cardiac Monitor |
| Vbi Vaccine (Delaware) INC. | $16.14 | 2023 | Prehevbrio |
| Xeris Pharmaceuticals, INC. | $15.13 | 2024 | Gvoke Hypopen |
| Seqirus USA INC | $14.62 | 2022 | |
| Avanir Pharmaceuticals, INC. | $14.53 | 2021 | |
| Kaleo, INC. | $12.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.